Is Abbott Losing Share in Key Medtech Markets?
By and large, Abbott Laboratories had a phenomenal second quarter this year – and investors took notice. The company's stock hit its highest point since 1995 on Wednesday after beating Wall Street's quarterly expectations and raising its own outlook for 2018.
Abbott, MD+DI's 2017 Medtech Company of the Year, clearly has a lot to celebrate as it continues to show the world what its made of. But at least one medtech analyst noticed that the company appears to have lost market share in cardiac rhythm management (CRM) and neuromodulation.
Abbott reported CRM sales of $543 million in the second quarter, representing a growth...
Source: MDDI - July 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Cardiovascular Source Type: news
Medical News Today: Deep brain stimulation 'slows Parkinson's progression'
A recently published study finds that deep brain stimulation, used in early-stage Parkinson's disease, could slow the progression of tremor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 30, 2018 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news
Deep brain stimulation 'slows Parkinson's progression'
A recently published study finds that deep brain stimulation, used in early-stage Parkinson's disease, could slow the progression of tremor. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 30, 2018 Category: Neurology Tags: Parkinson's Disease Source Type: news
DBS treatment may slow the progression of Parkinson's tremor in early-stage patients
(Vanderbilt University Medical Center) Deep brain stimulation (DBS) may slow the progression of tremor for early-stage Parkinson's disease patients, according to a Vanderbilt University Medical Center study released in the June 29 online issue of Neurology ® , the medical journal of the American Academy of Neurology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2018 Category: International Medicine & Public Health Source Type: news
UCLA global health program aims to boost neurological care in South Africa
When it came to getting the best treatment for his parents ’ neurologic illnesses, Sam Miller and his family experienced frustration finding the right doctors in their home country of South Africa.Miller ’s mother, Brenda, developed multiple sclerosis in her late 20s, and his father, Winston, was diagnosed with Parkinson’s disease in his 60s.Over the four decades of his mother ’s illness before her death in 2008, the increasingly acute shortage of neurologists in South Africa made the top specialists there much sought-after and overworked. They had little time to talk through treatment options, much less provide se...
Source: UCLA Newsroom: Health Sciences - June 26, 2018 Category: Universities & Medical Training Source Type: news
Medtronic wins expanded FDA indications for Kyphon HV-R bone cement
Medtronic (NYSE:MDT) said yesterday it won expanded FDA 510(k) clearance for its Kyphon HV-R bone cement designed for the fixation of pathological fractures of the sacral vertebral body.
The Fridley, Minn.-based company’s Kyphon HV-R bone cement is now indicated for treating pathological fractures of the vertebral body due to osteoporosis, cancer or benign lesions using a cementoplasty procedure.
The cement is also indicated for the fixation of pathological fractures of the sacral vertebral body or ala using sacral vertebroplasty or sacroplasty, the company said.
“Patients who experience sacral insufficiency ...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Orthopedics Regulatory/Compliance Spinal Medtronic Source Type: news
Long-term DBS Linked to Less Psychosis, Falls in Parkinson's Long-term DBS Linked to Less Psychosis, Falls in Parkinson's
Ten-year follow-up of patients with Parkinson ' s disease who underwent subthalamic deep-brain stimulation (DBS) shows they had lower risk for psychosis and falls than those not receiving DBS.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 21, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Deep brain stimulation promising for mild Alzheimer's patients older than 65
Alzheimer's patients older than 65 benefit the most benefit from deep brain stimulation, according to findings from a recent phase II clinical trial. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 19, 2018 Category: Consumer Health News Source Type: news
Deep Brain Stimulation showing promise for patients with mild Alzheimer's disease over 65
(University Health Network) An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix (DBS-f), as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news
Medtronic's deep brain stimulation programmer and app get the FDA nod
Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. (Source: mobihealthnews)
Source: mobihealthnews - June 18, 2018 Category: Information Technology Source Type: news
Medtronic wins FDA nod for DBS clinician programmer
Medtronic (NYSE:MDT) said today it won FDA approval for its Deep Brain Stimulation clinician programmer and Activa programming application.
The Fridley, Minn.-based medtech giant said that the Activa programming application, which is designed for use with Samsung Galaxy Tab S2 tablets, is intended to streamline workflows and improve clinician programming for its Activa DBS system.
Medtronic said that the programmer will enable upgrades to Activa rechargeable implantable neurostims that will extend their lifespans to 15 years, giving patients an additional six years before they need device replacement. The newly cleared p...
Source: Mass Device - June 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Regulatory/Compliance Medtronic Source Type: news
Adaptive Deep-Brain Stimulation Promising for Parkinson's Adaptive Deep-Brain Stimulation Promising for Parkinson's
Researchers test a DBS device in development that automatically senses and adjusts delivery of electrical stimulation, aiming to avoid dyskinesia and other side effects of current technology.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 12, 2018 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Treatment Advances Give Hope to People with Brain Metastases
Treatment TermsMetastatic Brain and Spine Tumors
Author
Erin Hull
Overview
Lisa VanTress didn ’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016. When the dizziness caused her to stumble and fall, she went to the emergency room. She soon learned she had lung cancer that had spread to her brain.
Hero Imagebrainmets1932x862.jpg
Preview Image
Content Blocks
CTA Header
Learn More
CTA ButtonBrain and Spine Metastases
Patient Name
Lisa VanTress
Patient Photo
Featured Doctors
Peter E. Fecci, MD, PhD
Jeffrey Melson Clarke, MD
Scott R. Floyd, MD, Ph...
Source: dukehealth.org: Duke Health News - June 8, 2018 Category: Consumer Health News Authors: efh7 at duke.edu Source Type: news
Adaptive deep brain stimulation for Parkinson ’s disease
Researchers designed a self-tuning deep-brain stimulation device and tested it in two patients with Parkinson ’s disease. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 5, 2018 Category: Consumer Health News Source Type: news
Parkinson's: 'Adaptive' brain implant may improve therapy
Deep brain stimulation is used to improve the symptoms of Parkinson's disease, but it has many limitations. Can an innovative implant avoid the drawbacks? (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 2, 2018 Category: Neurology Tags: Parkinson's Disease Source Type: news
